Dr. Michael S. Bronze, MD

Dr. Bronze practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Bronze's NPI, 1235199209, was assigned on March 24, 2006. Dr. Bronze graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1982. Dr. Bronze holds Oklahoma license 21683.

Dr. Bronze's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Bronze's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Bronze is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Bronze to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bronze practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Bronze's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Bronze is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Bronze's licenses on file in 2 states: Oklahoma and Tennessee.

Dmand AI lists hepatitis c, pneumonia and respiratory infection, sepsis, urinary tract infection and UTI among the conditions Dr. Bronze treats.

CMS data shows 284 Medicare services from Dr. Bronze across 5 procedure codes in 2024, for 85 Medicare patients. Medicare paid $18,940 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 85 Medicare patients who saw Dr. Bronze in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bronze's median patient age at 70, with 46% women.

In 2024, Dr. Bronze wrote 382 Medicare Part D claims for 38 patients. 76% of them were for generic drugs. CMS names the drug for 185 of them, across 13 drugs with 11 or more claims each, at $139,539 in total drug cost. In 2023, CMS named 169 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Bronze for performance year 2024, reported as part of a group. Dr. Bronze accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 93 papers to Dr. Bronze, published from 2000 to 2025. 2016 was the busiest year, with 7. The most frequent topics are Cell Line, Tumor, Doublecortin-Like Kinases and Protein Serine-Threonine Kinases. Dr. Bronze has published most often in Am J Med Sci. Dr. Bronze's most frequent co-authors are William L. Berry, MD, Douglas A. Drevets, MD and Mark M. Huycke, MD.

Dr. Bronze graduated from University of Tennessee Health Science Center College of Medicine - Memphis in 1982.

Dr. Bronze is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.